The shares of leading consumer wellness firm rose by 4.6% to ₹2,318 per share a a day after Domestic Institutional bought 10.7 lakh equity shares.
In wednesday’s trading session,At 12:50 p.m, the shares of Zydus Wellness (NS:ZYDS) Ltd were trading at ₹2,317 per share,up 4.61 percent from its previous close.The company has a market capitalization of ₹14,702 crores.
Is Zydus Wellness a buy or sell? What is its Fair Value? What are the company's health parameters? What are the positive and negative factors driving the company -- ProTips? Know all the answers on the company's overview page here.
What is the news
According to NSE deals data, on August 6th, the Domestic Institutional Investor (DII) Quant Mutual Fund acquired 10.71 lakh shares, or 2.67%, of Zydus Wellness at an average price of ₹2,201.40 per share of ₹374 crores through an open market transaction. Meanwhile, Threpsi Care LLP sold 17 lakh shares at an average price of ₹2,201.40 per share.
About the company
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.
Zydus Wellness, through its flagship brand Sugar Free, has maintained a dominant market share of around 95% in the sugar substitute category in India.
Recently,Zydus Wellness has entered new markets, including New Zealand and Kenya, and plans to manage its international operations through its subsidiary, Zydus Wellness International DMCC.
Additionally,The company has introduced Complan Nutrigro, targeting the toddler health food segment, and Glucon-D Immuno Volts, which is fortified with vitamins to boost immunity.
Financials:
In Q1 FY25, the company’s revenue increased by 20% year-on-year, rising from ₹702 crore to ₹841 crore. while, net profit has increased by 35%, from ₹110 crore to ₹148 crore during the same period.
Zydus Wellness shares have experienced significant growth, appreciating by 41% over the past six months and 57% over the past twelve months.
According to the latest shareholding pattern, the company’s promoter holds a 69.92% stake, Foreign Institutional Investors hold a 3.29% stake, and Domestic Institutional Investors hold a 19.44% stake.
Written by Omkar Chitnis
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Smallcap stock jumps 4% after Quant Mutual Fund bought 2.67% stake in the company appeared first on Trade Brains.
To understand more about InvestingPro, watch this video: https://www.youtube.com/watch?v=_WfQcN5vjIE